Microfluidic filtration system to isolate extracellular vesicles from blood

Area of Science:

• Biotechnology
• Nanotechnology
• Cancer Research

Background:

• Extracellular vesicles (EVs) are released by tumor cells and show promise for blood-based cancer diagnostics.
• Current EV purification methods are often inefficient, lack standardization, or damage the vesicles.

Purpose of the Study:

• To develop a simple, effective microfluidic strategy for isolating intact extracellular vesicles from whole blood.
• To improve the purity and yield of EVs for downstream analysis in cancer diagnostics.

Main Methods:

• Fabrication of microfluidic chips with in situ prepared nanoporous polymer monolith membranes.
• Utilizing size exclusion filtration and DC electrophoresis for EV separation from blood components.
• Isolation of EVs from whole blood of melanoma-bearing mice.

Main Results:

• Successfully isolated intact extracellular vesicles from whole blood using the microfluidic filtration system.
• Demonstrated enrichment of melanoma-specific RNA (Melan A mRNA) in isolated EVs via RT-PCR.
• The developed method avoids laborious centrifugation and non-specific antibody purification.

Conclusions:

• The microfluidic filtration system offers a simple, standardized approach for EV isolation from blood.
• This technology has potential for integrated sample preparation in liquid biopsy applications for cancer detection.
• The method preserves EV integrity and cargo, facilitating accurate downstream analysis.